Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UK-453,061 (Lersivirine) in Asymptomatic HIV
NCT00348673Phase 2Completed
- Sponsor
- Pfizer
- Start
- Feb 2006
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lersivirine in human immunodeficiency virus type 1 infection (HIV-1) (2 arms), sponsored by Pfizer. Primary endpoint: Change From Baseline in Human Immunodeficiency Virus-1 (HIV-1) Viral Load at Day 8. Started Feb 2006; status: completed.
02
Drugs
lersivirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00348673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00348673.